“Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes: A Narrative Review of Who Needs Fibrosis Staging and When” (2023) Journal of Clinical Diabetes and Obesity, 3(1), pp. 19–24. doi:10.5281/zenodo.22258263.